DrugPatentWatch Database Preview
TOSYMRA Drug Profile
» See Plans and Pricing
Which patents cover Tosymra, and what generic alternatives are available?
Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. There are seven patents protecting this drug.
This drug has sixty-one patent family members in nineteen countries.
The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tosymra
A generic version of TOSYMRA was approved as sumatriptan by LANNETT CO INC on February 19th, 2016.
Summary for TOSYMRA
| International Patents: | 61 |
| US Patents: | 7 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TOSYMRA |
| What excipients (inactive ingredients) are in TOSYMRA? | TOSYMRA excipients list |
| DailyMed Link: | TOSYMRA at DailyMed |
Pharmacology for TOSYMRA
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1d Receptor Agonists Serotonin 1b Receptor Agonists |
US Patents and Regulatory Information for TOSYMRA
International Patents for TOSYMRA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Brazil | PI0923403 | Get Started for $10 |
| Japan | 2012513412 | Get Started for $10 |
| World Intellectual Property Organization (WIPO) | 2006025882 | Get Started for $10 |
| United Kingdom | 202012086 | Get Started for $10 |
| Russian Federation | 2018107419 | Get Started for $10 |
| Russian Federation | 2011130526 | Get Started for $10 |
| European Patent Office | 1789075 | Get Started for $10 |
| >Country | >Patent Number | >Estimated Expiration |
